Corvia Medical supports V-Wave's RELIEVE-HF data.

Corvia Medical supports V-Wave's RELIEVE-HF data, highlighting the importance of patient selection in atrial shunt therapy trials. Although RELIEVE-HF did not reduce heart failure events in HFpEF patients, it emphasizes the need for selecting patients with characteristics likely to benefit from atrial shunting. Corvia's global RESPONDER-HF trial of the Corvia® Atrial Shunt is ongoing.

April 12, 2024
4 Articles

Further Reading